The impact of ageing on stroke subtypes, length of stay and mortality: Study in the province of Teruel, Spain

Acta Neurologica Scandinavica

Volumn 108, Issue 6, 2003, Pages 435-442

  Modrego, P J ^a,c   Pina, M A ^b   Lerin F J ^b  

^a Hosp del Insalud de Alcaniz   (Spain)

^b HOSPITAL OBISPO POLANCO   (Spain)

^c NONE   (Spain)

Author keywords

Elderly population; Fatality rates; Mortality by stroke; Spain; Stroke subtypes; Teruel

Indexed keywords

AGED; AGING; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FATALITY; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PROSPECTIVE STUDY; PUBLIC HOSPITAL; SPAIN; STROKE;

AGE FACTORS; AGED; AGING; CEREBROVASCULAR ACCIDENT; DATA COLLECTION; EPISODE OF CARE; FEMALE; HUMANS; LENGTH OF STAY; MALE; RISK FACTORS; SPAIN; SURVIVAL ANALYSIS;

EID: 0344872821     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2003.00168.x     Document Type: Article

References (34)

1. HOWARD G, HOWARD VJ, KATHOLI C, OLI MK, HUSTON S. Decline in US stroke mortality. An analysis of temporal patterns by sex, race, and geographic region. Stroke 2001;32:2213-20.
2. SARTI C, RASTENYTE D, CEPAITIS Z, TUOMILEHTO J. International trends in mortality from stroke, 1968 to 1994. Stroke 2000;31:1588-1601.
3. SHAHAR E, MCGOVERN PG, PANKOW JS et al. Stroke rates during the 1980s: the Minnesota Stroke Survey. Stroke 1997;28:275-9.
4. COOPER R, SEMPOS C, HSIEH SC, KOVAR MG. Slowdown in the decline of stroke mortality in the United States, 1978-1986. Stroke 1990;21:1274-9.
5. BROWN RD, WHISNANT JP, SICKS JD, O'FALLON WM, WIEBERS DO. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 1996;27:370-2.
6. DERBY CA, LAPANE KL, FELDMAN HA, CARLETON RA. Trends in validated cases of fatal and nonfatal stroke, stroke classification, and risk factors in southeastern New England, 1980 to 1981: data from the Pawtucket Heart Health Program. Stroke 2000;31:875-81.
7. BARRADO-LANZAROTE MJ, DE PEDRO CUESTA J, ALMAZÁN-ISLA J. Stroke mortality in Spain, 1901-1986. Neuroepidemiology 1993;12:148-57.
8. BARRADO-LANZAROTE MJ, ALMAZÁN-ISLA J, MEDRANO-ALBERO MJ, DE PEDRO CUESTA J. Spatial distribution of stroke mortality in Spain, 1975-1996. Neuroepidemiology 1995;14:165-73.
9. MEDRANO MJ, LOPEZ ABENTE G, BARRADO MJ, POLLAN M, ALMAZÁN J. Effect of age, birth cohort, and period of death on cerebrovascular mortality in Spain: 1952 through 1991. Stroke 1997;28:40-4.
10. ABADAL LT, PUIG T, BALAGUER VINTRO I. Incidence, mortality and risk factors for stroke in the Manresa study: 28 years of follow-up. Rev Esp Cardiol 2000;53:15-20.
11. CAYUELA DOMINGUEZ A, RODRIGUEZ DOMINGUEZ S, LAPETRA PERALTA J, GIL PERALTA A, RODRIGUEZ ARCE A. Stroke: trends in mortality in Andalucia (Spain), 1975-1992. Neuroepidemiology 1997;16:99-106.
12. FANG J, ALDERMAN MH. Trend of stroke hospitalisation, United States, 1988-1997. Stroke 2001;32:2221-6.
13. ARBOIX A, GARCIA EROLES L, MASSONS J, OLIVERES M, TARGA C. Acute stroke in very old people: clinical features and predictors of in-hospital mortality. J Am Geriatr Soc 2000;48:36-41.
14. ASPLUND K. The decline in stroke mortality: an ending or a never-ending story? Stroke 2001;32:2218-9.
15. World Health Organization. Diabetes mellitus: Report of a WHO study group. Technical Report Series 727. Geneva: WHO; 1985.
16. BOGOUSSLAVSKY J, VAN MELLE G, REGLI F. The Lausanne stroke registry: analysis of 1000 consecutive patients with first stroke. Stroke 1988;19:1083-92.
17. SUDLOW CLM, WARLOW CP. Comparing stroke incidence worldwide: what makes studies comparable? Stroke 1996;27:550-8.
18. GARDNER MJ, ALTMAN DG. Statistics with confidence. London: British Medical Journal Publications; 1989.
19. THORVALDSEN P, ASPLUND K, KUULASMAA K, RAJAKANOAS AM, SCHROLL M. Stroke incidence, case fatality, and mortality in the WHO MONICA Project. Stroke 1995;26:361-7.
20. BAPTISTA MV, VAN MELLE G, BOGOUSSLAVSKY J. Prediction of in-hospital mortality after first-ever stroke: the Lausanne stroke registry. J Neurol Sci 1999;166:107-14.
21. MIHALKA L, SMOLANKA V, BULECZA B, MULESA S, BERECZKI D. A population study of stroke in West Ukraine: incidence, stroke services, and 30-day case fatality. Stroke 2001;32:2227-31.
22. KITA Y, AKAYAMA A, UESHIMA H et al. Stroke incidence and case fatality in Shiga, Japan 1989-1993. Int J Epidemiol 1999;28:1059-65.
23. ROCCA WA, REGGIO A, SAVETTIERI G et al. Stroke incidence and survival in three sicilian municipalities. Sicilian neuroepidemiologic study (SNES) group. Ital J Neurol Sci 1998;19:351-6.
24. WOLFE CD, TAUB NA, WOODROW J, RICHARDSON E, WARBURTON FG, BURNEY PG. Does the incidence, severity, or case fatality of stroke vary in southern England? J Epidemiol Community Health 1993;47:139-43.
25. ROBERTS SE, GOLDACRE MJ. Case fatality rates after admission to hospital with stroke: linked database study. BMJ 2003;326:193-4.
26. MODREGO PJ, PINA MA, FRAJ MM, LLORENS N. Type, causes, and prognosis of stroke recurrence in the province of Teruel, Spain. A 5-year analysis. Neurol Sci 2000;21:355-60.
27. NUMMINEN H, KASTE M, AHO K, WALTIMO O, KOTILA M. Decreased severity of brain infarct can in part explain the decreasing case fatality rate of stroke. Stroke 2000;31:651-5.
28. WOLF PA, D'AGOSTINO RB. Secular trends in stroke in the Framingham study. Ann Epidemiol 1993;3:471-4.
29. FOULKES MA, WOLF WA, PRICE TR, MOHR JP, HIER DB. The stroke data bank: design, methods, and baseline characteristics. Stroke 1988;19:547-54.
30. GRAU AJ, WEIMAR C, BUGGLE F et al. Risk factors, outcome, and treatment in subtypes of ischaemic stroke. The German stroke data bank. Stroke 2001;32:2559-66.
31. MARTI-VILALTA JL, ARBOIX A. The Barcelona stroke registry. Eur Neurol 1999;41:135-42.
32. ARBOIX A, MASSONS J, OLIVERES M, GARCÍA L, TITUS F. Analisis de 1000 pacientes consecutivos con enfermedad cerebrovascular aguda. Registro de enfermedad cerebrovascular del Hospital Central de La Alianza de Barcelona. Med Clin (Barc) 1993;101:281-5.
33. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischaemic stroke: a randomized controlled trial. J Am Med Assoc 1998;279:1265-72.
34. PETTY GW, BROWN RD, WHISNANT JP, SICKS JRD, O'FALLON WM, WIEBERS DO. Ischaemic stroke subtypes: a population-based study of incidence and risk factors. Stroke 1999;30:2513-6.